The Use of p48/64 MW HPC Flow Modulation Device in Wide-necked Intracranial Aneurysms
This study looks at a device called the **p48/p64 MW HPC Flow Modulation Device**. It's used to treat **wide-necked intracranial aneurysms (IA)**, which are bulges in blood vessels in the brain. These aneurysms are dangerous because they can burst, causing bleeding in the brain. Researchers want to see if the device can safely and effectively treat these aneurysms.
Key Points:
- The study lasts for 12 months after the procedure.
- You must be 18 or older and meet certain health criteria to join.
- Some people, like those with certain allergies or recent surgeries, cannot participate.
To join, you must have a specific type of unruptured aneurysm. You can't join if you've had certain treatments or conditions, like a recent brain bleed or major surgery. Participants need to agree to follow the study procedures and attend follow-up visits. It's important to talk to your doctor to see if this study is right for you.
How understandable was the trial content above?
Hard to understand
Easy to understand